Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[White-coat hypertension]

P Verdecchia1, C Porcellati

  • 1Area Omogenea Di Cardiologia E Medicina, Ospedale Generale Regionale R. Silvestrini, Perugia.

Giornale Italiano Di Cardiologia
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of emergency calls for time-dependent acute illnesses during COVID-19 outbreak in Umbria region (Italy).

Annali di igiene : medicina preventiva e di comunita·2020
Same author

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Same author

Ambulatory blood pressure monitoring in the elderly: features and perspectives.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Posterior lacrimal sac approach technique without stenting in endoscopic dacryocystorhinostomy.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2013
Same author

[Systolic, diastolic and pulse pressure: prognostic implications].

Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·2009
Same author

Observational study of hypertension in Matelica, Italy (Matelica hypertension study).

Clinical and experimental hypertension (New York, N.Y. : 1993)·2007
Same journal

[Proceedings of the National Cardiology Conference on Cardiac Emergencies: Prospect for the year 2000. Rome, Italy, 15-16 October 1999].

Giornale italiano di cardiologia·2001
Same journal

[Heart rupture in acute myocardial infarction: advantages of the use of Doppler color echocardiography M-2D in coronary intensive care unit].

Giornale italiano di cardiologia·2000
Same journal

[Risk identification and strategy for the prevention of sudden cardiac death after myocardial infarction].

Giornale italiano di cardiologia·2000
Same journal

[Arrhythmic complications in patients with heart decompensation: when and how to treat].

Giornale italiano di cardiologia·2000
Same journal

[Suboptimal exercise test in chronic heart decompensation: the six-minute walking test].

Giornale italiano di cardiologia·2000
Same journal

[Orthostatic tachycardia syndrome. Update on etiology, diagnosis and treatment].

Giornale italiano di cardiologia·2000
See all related articles

White-coat hypertension, characterized by high clinic blood pressure (BP) and normal ambulatory BP, is a low-risk form of essential hypertension. Individuals with this condition experience fewer cardiovascular complications compared to those with sustained hypertension.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Clinical Medicine

Context:

  • White-coat hypertension (WCH) is defined by elevated clinic blood pressure (BP) despite normal ambulatory or self-measured BP.
  • It is increasingly recognized as a low-risk variant of essential hypertension, not a distinct disease entity.
  • Ambulatory BP monitoring (ABPM) or self-measured BP is crucial for identifying WCH.

Purpose:

  • To define white-coat hypertension (WCH) using specific blood pressure (BP) thresholds.
  • To review evidence regarding target organ damage (TOD) in WCH.
  • To assess the cardiovascular risk associated with WCH compared to sustained hypertension and normotension.

Summary:

  • WCH is defined by clinic BP >140/90 mmHg with daytime ambulatory BP <130/80 mmHg (or <134/90 mmHg) in untreated essential hypertension.

Related Experiment Videos

  • Studies suggest similar or lesser target organ damage in WCH compared to sustained hypertension.
  • Evidence indicates a low cardiovascular risk profile for WCH patients, comparable to normotensive individuals.

    • Impact:

    • WCH represents a low-risk stratum of essential hypertension, aiding in risk stratification.
    • Findings suggest that antihypertensive drug treatment may not be necessary for uncomplicated WCH patients.
    • Further research is needed to confirm the long-term prognosis and optimal management of WCH.